Allergan Inc. Announces Launch Of JUVEDERM(TM) ULTRA And JUVEDERM(TM) ULTRA PLUS

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE:AGN), the maker of BOTOX(R) Cosmetic (Botulinum Toxin Type A), today announced it is launching its 'next-generation' hyaluronic acid dermal filler products, JUVEDERM(TM) ULTRA and JUVEDERM(TM) ULTRA PLUS, through an experience trial involving a group of physicians with expertise in facial aesthetics, in advance of nationwide product availability in January 2007. Allergan will begin accepting physician pre-orders for the products on November 1, 2006 via its nationwide sales force.